文献速递神经免疫头痛与眩晕认知障碍与痴呆

跨性状孟德尔随机化研究探讨偏头痛是否为多发性硬化的危险因素

Cross-Trait Mendelian Randomization Study to Investigate Whether Migraine Is a Risk Factor for Multiple Sclerosis.
PubMed 文献 · Neurology · 2023-01-11

研究利用公开的全基因组关联研究汇总数据(多发性硬化 N=115748,偏头痛 N=375752 和 N=361141)及 Kaiser Permanente 北加州健康计划的病例对照研究(N=1991),检验偏头痛是否为多发性硬化的危险因素。两样本孟德尔随机化未发现偏头痛为多发性硬化因果危险因素的证据(p=0.29),但鉴定出 4 个共享的主要组织相容性复合体位点。在北加州多发性硬化队列中,39%(774 例)经历偏头痛,合并偏头痛者更可能曾吸烟(OR=1.30,95%CI 1.08-1.57)、自我报告认知缺陷更差(OR=1.04,95%CI 1.02-1.06)及曾经历抑郁(OR=1.48,95%CI 1.22-1.80)。

要点

  • 孟德尔随机化未支持偏头痛是多发性硬化的因果危险因素(p=0.29)。
  • 多发性硬化与偏头痛共享 4 个主要组织相容性复合体位点。
  • 多发性硬化合并偏头痛者更可能曾吸烟、认知缺陷更差及曾经历抑郁。

核心结论

  • 研究结果不支持偏头痛作为多发性硬化的因果危险因素。
  • 若干遗传变异,尤其位于主要组织相容性复合体,可能解释部分重叠。
  • 多发性硬化背景下的偏头痛似乎很可能是多发性硬化所致。
  • 识别多发性硬化中偏头痛风险增加的因素可能改善治疗和生活质量。

研究设计与样本

  • 研究数据来自公开的全基因组关联研究汇总统计(多发性硬化 N=115748;偏头痛 N=375752 和 N=361141)及 Kaiser Permanente 北加州健康计划的病例对照研究(N=1991)。
  • 使用两样本孟德尔随机化检验偏头痛遗传工具变量是否与多发性硬化相关。
  • 使用连锁不平衡得分回归和 LOGODetect 判断多发性硬化与偏头痛是否在全基因组和区域共享遗传变异。
  • 使用北加州多发性硬化队列的逻辑回归分析合并偏头痛者与不合并者的临床特征或疾病特异性危险因素比值比。

主要发现

  • 未发现支持偏头痛为多发性硬化因果危险因素的证据(p=0.29)。
  • 鉴定出多发性硬化与偏头痛共享的 4 个主要组织相容性复合体位点。
  • 北加州多发性硬化队列中 774 例(39%)经历偏头痛。
  • 合并偏头痛者更可能曾吸烟(OR=1.30,95%CI 1.08-1.57)。
  • 合并偏头痛者自我报告认知缺陷更差(OR=1.04,95%CI 1.02-1.06)且更可能曾经历抑郁(OR=1.48,95%CI 1.22-1.80)。

关键数值与推荐

  • 偏头痛遗传工具变量与多发性硬化的孟德尔随机化分析 p=0.29。
  • 多发性硬化与偏头痛共享 4 个主要组织相容性复合体位点。
  • 合并偏头痛者曾吸烟的 OR=1.30(95%CI 1.08-1.57)。
  • 合并偏头痛者自我报告认知缺陷的 OR=1.04(95%CI 1.02-1.06)。
  • 合并偏头痛者曾经历抑郁的 OR=1.48(95%CI 1.22-1.80)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Migraine is common among people with multiple sclerosis (MS), but the reasons for this are unknown. We tested 3 hypothesized mechanisms for this observed comorbidity, including migraine is a risk factor of MS, genetic variants are shared between the conditions, and migraine is because of MS. METHODS: Data were from 2 sources: publicly available summary statistics from genome-wide association studies of MS (N = 115,748) and migraine (N = 375,752 and N = 361,141) and a case-control study of MS recruited from the Kaiser Permanente Northern California Health Plan (N = 1,991). For the latter participants, migraine status was ascertained using a validated electronic health record migraine probability algorithm or self-report. Using the public summary statistics, we used 2-sample Mendelian randomization to test whether a migraine genetic instrumental variable was associated with MS. We used linkage disequilibrium score regression and LOGODetect to ascertain whether MS and migraine shared genetic variants across the genome and regionally. Using the Northern California MS cohort, we used logistic regression to identify whether people with both MS and migraine had different odds of clinical characteristics (e.g., age at MS onset, Perceived Deficits Questionnaire, and depression) or MS-specific risk factors (e.g., body mass index, smoking status, and infectious mononucleosis status) compared with people with MS without migraine. RESULTS: We did not find evidence supporting migraine as a causal risk factor of MS (p = 0.29). We did, however, identify 4 major histocompatibility complex (MHC) loci shared between MS and migraine. Among the Northern California MS cohort, 774 (39%) experienced migraine. People with both MS and migraine from this cohort were more likely to ever smoke (odds ratio [OR] = 1.30, 95% CI: 1.08-1.57), have worse self-reported cognitive deficits (OR = 1.04, 95% CI: 1.02-1.06), and ever experience depression (OR = 1.48, 95% CI: 1.22-1.80). DISCUSSION: Our findings do not support migraine as a causal risk factor of MS. Several genetic variants, particularly in the MHC, may account for some of the overlap. It seems likely that migraine within the context of MS is because of MS. Identifying what increases the risk of migraine within MS might lead to an improved treatment and quality of life.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Horton MK, Robinson SC, Shao X, et al. Cross-Trait Mendelian Randomization Study to Investigate Whether Migraine Is a Risk Factor for Multiple Sclerosis. Neurology. 2023. PMID: 36631270. doi:10.1212/WNL.0000000000206791

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。